Commitment to achieving Net Zero
LFB Biomedicaments is committed to achieving Net Zero emissions by 2050.
Baseline Emissions Footprint
Baseline emissions are a record of the greenhouse gases that have been produced in the past and were produced prior to the introduction of any strategies to reduce emissions.
Baseline emissions are the reference point against which emissions reduction can be measured.
| Baseline Year: reporting of 2022 | |
| Additional Details relating to the Baseline Emissions calculations. | |
| Baseline year emissions: 2022 – This is the first year in which LFB has carried out the most complete carbon assessments based on its constant methodology / scope improvement approach and the GHG Protocol Corporate Accounting and Reporting Standard methodology. | |
| EMISSIONS | TOTAL (tCO2e) |
| Scope 1 | 3 248 |
| Scope 2 | 14 159 |
| Scope 3 (Included Sources) |
63 330 |
| Total Emissions | 80 738 |
Current Emissions Reporting
| Reporting Year: 2023 | |
| EMISSIONS | TOTAL (tCO2e) |
| Scope 1 | 6 383 |
| Scope 2 | 18 329 |
| Scope 3 (Included Sources) |
30 144 |
| Total Emissions | 54 856 |
Emissions reduction targets
LFB uses the GHG Protocol Corporate Accounting and Reporting Standard methodology to calculate its carbon footprint. Since 2017, the company has published its Scopes 1, 2 and 3.
The company has definied decarbonization targets for Scopes 1, 2 and 3. LFB has clear goals established in its 2030 Agenda, leading a 43% reduction in its carbon trajectory to 2022.
This reduction represents an absolute decrease of 34 717 tCO2eq.
Progress against these targets can be seen in the graph below:
Carbon Reduction Projects
The Completed Carbon Reduction Initiatives
The decarbonization plan for Scopes 1, 2 and 3 was developped on the results of a strong and detailed energy audit of LFB BIOMEDICAMENTS’ industrial sites. The 28 projects that make up the plan, the progess of which is monitored monthly by the Executive committee, in terms of timelines, as well as associated means and resources.
The preparation for ISO 50001 certification by 2026 will sustainably support the reduction of Scopes 1 and 2, and the improvement of LFB’s energy efficiency.
Regarding Scope 3, action are being taken to contribute its reduction, such as our Traval Policy to minimize carbon emissions in business trips and employee travels, the inclusion of the right to telecommute (up to 2days/week), or the increase in the fleet of electric and hybrid vehicles in the company car offering. Additional projects are underway, such as the reduction and reuse of our inputs, or the creation of a circular economy loop in the treatment of our healthcare waste.
Declaration and Sign Off
This Carbon Reduction Plan has been completed in accordance with PPN 06/21 and associated guidance and reporting standard for Carbon Reduction Plans.
Emissions have been reported and recorded in accordance with the published reporting standard for Carbon Reduction Plans and the GHG Reporting Protocol corporate standard and uses the appropriate Government emission conversion factors for greenhouse gas company reporting.
Scope 1 and Scope 2 emissions have been reported in accordance with SECR requirements, and the required subset of Scope 3 emissions have been reported in accordance with the published reporting standard for Carbon Reduction Plans and the Corporate Value Chain (Scope 3) Standard.
This Carbon Reduction Plan has been reviewed and signed off by the board of directors (or equivalent management body).